Showing results (1601-1610 of 1,675) with videos related to
Sort By:
Pageof 168
The Pediatric Infectious Disease Journal|June 3, 2024
Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled TrialHing C Kok, Gabrielle B McCallum, Stephanie T Yerkovich, et al.Cell|June 7, 2025
Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effectsOrlando DeLeon, Mora Mocanu, Alan Tan, et al.Archives of Disease in Childhood|May 9, 2025
Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trialHing Cheong Kok, Stephanie T Yerkovich, Gabrielle B McCallum, et al.BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.BMJ Open Respiratory Research|May 8, 2024
Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trialAnne B Chang, Stephanie T Yerkovich, Katherine J Baines, et al.Science (New York, N.Y.)|June 18, 2026
Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprintingHao Fan, Zhong Zheng, Kaitlyn Oliphant, et al.American Journal of Human Genetics|July 15, 2025
A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemiaJeremy B Chang, Connor P Barnhill, Alexander M Apostolov, et al.BMJ Open Respiratory Research|May 9, 2022
Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trialAnne B Chang, Lucy C Morgan, Emma L Duncan, et al.Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.Gut Microbes|December 18, 2025
Impacts of COVID-19 pandemic on early life gut microbiomeLin Zhang, Wenye Xu, Henry Y H Meng, et al.Pageof 168